Identifying Natural Derived Upregulators of Human ApoA-I Expression via a Cell-Based Drug Screening System

References

• G Assmann, AV Eckardstein, and HB Brewer. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. McGraw-Hill, New York, (2001)2937–2980.
   Google Scholar
• EA Brinton, S Eisenberg, and JL Breslow. (1989). Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. J Clin Invest 84:262–269.
   PubMed Web of Science ®Google Scholar
• EA Brinton, S Eisenberg, and JL Breslow. (1990). A low-fat diet decreases high density lipoprotein (HDL) cholesterol levels by decreasing HDL apolipoprotein transport rates. J Clin Invest 85:144–51.
   PubMed Web of Science ®Google Scholar
• CG Brouillette, GM Anantharamaiah, JA Anglers, and DW Borhani. (2001). Structural models of human apolipoprotein A-I: A critical analysis and review. Biochim Biophys Acta 1531:4–46.
   PubMed Web of Science ®Google Scholar
• KS Chong, RJ Nicolosi, RF Rodger, DA Arrigo, RW Yuan, JJ MacKey, S Georas, and PN Herbert. (1987). Effect of dietary fat saturation on plasma lipoproteins and high density lipoprotein metabolism of the rhesus monkey. J Clin Invest 79:675–683.
   PubMedGoogle Scholar
• N Duverger, H Kruth, F Emmanuel, JM Caillaud, C Viglietta, G Castro, A Tailleux, C Fievet, CJ Fielding, and PE Fielding. (1995). Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211–228.
   Google Scholar
• TM Forte, and MR McCall. (1994). The role of apolipoprotein A-I-containing lipoproteins in atherosclerosis. Curr Opin Lipidol 5:354–364.
   Google Scholar
• JC Fruchart, and P Duriez. (1998). High density lipoproteins and coronary heart disease. Future prospects in gene therapy. Biochimie 80:167–72.
   Google Scholar
• JC Fruchart, LM Houdebine, and P Denefle. (1996). Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation 94:713–717.
   Google Scholar
• T Gordon, WB Kannel, WP Castelli, and TR Dawber. (1981). Lipoproteins, cardiovascular disease, and death. The Framingham Study. Arch Intern Med 141:1128–1131.
   PubMed Web of Science ®Google Scholar
• SL Hsu, YC Hsieh, WC Hsieh, and CJ Chou. (2001). Baicalein induces a dual growth arrest by modulating multiple cell cycle regulatory molecules. Eur J Pharmacol 425:165–171.
   PubMed Web of Science ®Google Scholar
• Y Huanga, SY Tsanga, XQ Yaoa, and ZY Chenb. (2005). Biological properties of baicalein in cardiovascular system. Curr Drug Targets Cardiovasc Haematol Disord 5:177–184.
   Google Scholar
• PO Kwiterovich. (1998). The antiatherogenic role of high-density lipoprotein cholesterol. Am J Cardiol 82:13Q–21Q.
   PubMed Web of Science ®Google Scholar
• RC LeBoeuf, MH Doolittle, A Montcalm, DC Martin, K Reue, and AJ Lusis. (1990). Phenotypic characterization of the Ath-1 gene controlling high density lipoprotein levels and susceptibility to atherosclerosis. J Lipid Res 31:91–101.
   Google Scholar
• P Linsel-Nitschke, and AR Tall. (2005). HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat Rev Drug Discov 4:193–205.
   PubMed Web of Science ®Google Scholar
• JS Parks, and LL Rudel. (1982). Different kinetic fates of apolipoproteins A-I and A-II from lymph chylomicra of nonhuman primates. Effect of saturated versus polyunsaturated dietary fat. J Lipid Res 23:410–421.
   PubMedGoogle Scholar
• EM Rubin, BY Ishida, SM Clift, and RM Krauss. (1991). Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-l and the appearance of two new high density lipoprotein size subclasses. Proc Natl Acad Sci USA 88:434–438.
   PubMed Web of Science ®Google Scholar
• J Sambrook, and DW Russell. Molecular Cloning: A Laboratory Manual, 3rd ed.. Cold Spring Harbor Laboratory Press, Cold Spring HarborNY, (2001)1361–1362.
   Google Scholar
• EJ Schaefer, LA Zech, LL Jenkins, TJ Bronzert, EA Rubalcaba, FT Lindgren, RL Aamodt, and HB BrewerJr. (1982). Human apolipoprotein A-I and A-II metabolism. J Lipid Res 23:850–862.
   PubMed Web of Science ®Google Scholar
• PK Shah. (2003). Emerging non-statin LDL-lowering therapies for dyslipidemia and atherosclerosis. Rev Cardiovasc Med 4:136–141.
   PubMedGoogle Scholar
• YC Shen, WF Chiou, YC Chou, and CFu Chen. (2003). Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes. Eur J Pharmacol 465:171–181.
   PubMed Web of Science ®Google Scholar
• J Shepherd, CJ Packard, JR Patsch, AM GottoJr, and OD Taunton. (1978). Effects of dietary polyunsaturated and saturated fat on the properties of high density lipoproteins and the metabolism of apolipoprotein A-I. J Clin Invest 61:1582–1592.
   PubMed Web of Science ®Google Scholar
• CR Sirtori. (2004). New frontiers in atherosclerosis prevention and treatment: HDL as a novel therapeutic target. Int Congr Ser 1262:9–14.
   Google Scholar
• AR Tall. (1990). Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J Clin Invest 86:379–384.
   PubMed Web of Science ®Google Scholar
• MS Thomas, and MW Kearns. (1991). Transcriptional regulation of the apolipoprotein A-I gene, species-specific expression correlates with rates of gene transcription. J Biol Chem 266:18045–18050.
   Google Scholar
• MS Thomas, MM Prack, N Dashti, F Johnson, LL Rudel, and DL Williams. (1989). Differential effects of dietary fat on the tissue-specific expression of the apolipoprotein A-I gene: Relationship to plasma concentration of high density lipoproteins. J Lipid Res 30:1397–1403.
   Google Scholar
• EI Waddington, E Boadu, and GA Francis. (2005). Cholesterol and phospholipids efflux from cultured cells. Methods 36:196–206.
   Google Scholar
• N Wang, DL Silver, C Thiele, and AR Tall. (2001). ATP-binding Cassette Transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem 276:23742–23747.
   PubMed Web of Science ®Google Scholar
• KS Woo, C Chook, OT Raitakari, B McQuillan, JZ Feng, and DS Celermajer. (1999). Westernization of Chinese adults and increased subclinical atherosclerosis. Arterioscler Thromb Vasc Biol 19:2487–2493.
   PubMed Web of Science ®Google Scholar
• XL Zheng, S Matsubara, C Diao, MD Hollenberg, and NCW Wong. (2000). Activation of apolipoprotein AI gene expression by protein kinase A and kinase C through transcription factor, Sp1. J Biol Chem 275:31747–31754.
   PubMedGoogle Scholar